11th Annual Conference of the Baltic Network Against Life-threatening Viral Infections
Apskatīt komentārus (0)
27.01.2014
Topics for 24-27 April, 2014:
- Molecular Virology of HCV, HIV and TB
- HCV Patology and Immunology
- HCV, HBV, HIV and TB Epidemiology & Diagnostics
- Vaccine Development
- HIV and AI (associated infections)
- Communicable co-morbidities
- Social aspects of HIV and AI, Targeted prevention
- Treatment for Prevention, Adherence and Resistance
- Post- and pre-exposure prophylaxis
- HIV and non-infections burdening conditions
(alcohol and drug dependence)
The Conference will be followed by the 4th two-day open lecture course on Hepatitis, HIV and co-infections ABC
28-29 April, 2014 in Vilnius at Vilniaus kolegija.
-----------------------------------------------------
In 2002, the Malmo University Hospital and Lund University (Coordinators) have created a Network along with the Swedish Institute for Infectious Diseases Control, Karolinska Institutet, Biomedical Research and Study Centre, Latvian University (Latvia), Academy of Sciences, Ivanovsky Institute of Virology, Moscow (Russia) to address the open questions on the correlates of clinical course and outcome of hepatitis C virus infection. The following partners have joined the network further: the Moscow State University of Medicine and Dentistry and the Institute of Cytology, St. Petersburg (Russia) in 2003, the Tartu University (Estonia) and the Belorussian State Medical University, Minsk (Belarus) in 2005, the National Institute for Health Development, Tallinn (Estonia) in 2008. The former Lithuanian AIDS Centre was incorporated in 2010.
The Partnership will continue the tradition of the Annual Conferences which disseminate the newest achievements in the field of biomedicine with application to life-threatening viral diseases. The first 10 meetings were held in Stockholm in 2003, Riga in 2005, Malmo in 2006, Moscow in 2007, Stockholm in 2008, Tallinn in 2009, Tartu in 2010, Vilnius in 2011, St. Petersburg in 2012, Riga in 2013, and where devoted majorly to viral hepatitis C and also other hepatotropic viral infections and co-infections. For example, presentations in the 10th Conference, held in Riga, Latvia, in 2013 covered the following areas: HCV molecular virology; clinical sequels and treatment of hepatitis C; HCV immunology and vaccine development; HCV epidemiology and social issues.
Since the Thematic Partnership against life-threatening viral infections in Balticum has broadened the area of biomedical research, the 11th Annual Conference of the Baltic Network Against Life-Threatening Viral Infections would provide a wider platform for discussion of results of research on blood-borne virus infections as HIV-1, viral hepatitis B and C, also enteral infections as viral hepatitis A and E, as well as influenza. This 11th meeting will be organized in Vilnius, Lithuania, in April 2014.
Another tradition is an Open Lecture Course HEPATITIS ABC for medical students, doctors and researchers, first held in Vilnius 2011, then at St Petersburg University 2012, and the Stradins Medical University in 2013. This course in 2014 will be broadened to include HIV-1 and AIDS, and viral co-infections. The course would follow the annual conference.
Read more at http://balticviralconference.com/
